https://education.nccn.org/node/84648
Case 1: Relapsed/Refractory Low-Grade Follicular Lymphoma | NCCN Continuing Education
nccn continuing educationfollicular lymphomacaserefractorylow
https://www.sciencedaily.com/releases/2014/06/140609093602.htm
Combination therapy may help patients with follicular lymphoma | ScienceDaily
Follicular lymphoma is an incurable form of non-Hodgkin lymphoma that is diagnosed each year in 120,000 people worldwide, and is characterized by slow and...
combination therapymay helpfollicular lymphomapatientssciencedaily
https://ega-archive.org/dacs/EGAC00001000086
Barts Cancer Institute - Follicular Lymphoma Whole Genome Sequencing Project Data Access Committee...
Barts Cancer Institute - Follicular Lymphoma Whole Genome Sequencing Project Data Access Committee
whole genome sequencingdata access committeecancer institutefollicular lymphomabarts
https://pure.fujita-hu.ac.jp/en/publications/follicular-lymphoma-suggested-to-transform-into-ebv-negative-plas/
Follicular lymphoma suggested to transform into EBV-negative plasmablastic lymphoma - Fujita Health...
follicular lymphomasuggestedtransformebvnegative
https://www.expresspharma.in/tag/relapsed-or-refractory-follicular-lymphoma/
relapsed or refractory follicular lymphoma Archives - Express Pharma
follicular lymphomaexpress pharmarefractoryarchives
https://healthtree.org/follicular-lymphoma/community/directory/ca/uc-irvine-health-orange-ca
UC Irvine Health Follicular Lymphoma Specialist - HealthTree
A Follicular Lymphoma specialist has the most up-to-date information, and can provide you with the best care to help you make decisions regarding your...
uc irvinefollicular lymphomahealthspecialist
https://haematologica.org/article/view/8571
Impact of age on genetics and treatment efficacy in follicular lymphoma | Haematologica
follicular lymphomaimpactagegeneticstreatment
https://pharmashots.com/26901/genmab-reports-p-iii-epcore-fl-1-trial-data-on-epcoritamab-for-r-r-follicular-lymphoma/
Genmab Reports P-III (EPCORE FL-1) Trial Data on Epcoritamab for R/R Follicular Lymphoma -...
follicular lymphomagenmabreportsiiifl
https://hccbuddy.com/icd10/C82.9
C82.9 ICD-10 Code: Follicular lymphoma | HCC Buddy
ICD-10-CM code C82.9: Follicular lymphoma, unspecified. HCC mapping, coding tips, and clinical details.
follicular lymphomaicdcodehccbuddy
https://www.clinicaltrialsarena.com/projects/aliqopa-copanlisib-treatment-relapsed-follicular-lymphoma/
Aliqopa (copanlisib) for the Treatment of Relapsed Follicular Lymphoma - Clinical Trials Arena
Apr 4, 2023 - Aliqopa (copanlisib) is a novel intravenous phosphatidylinositol-3-kinase (PI3K) inhibitor indicated for the treatment of adult patients with relapsed...
for thefollicular lymphomaclinical trialstreatmentarena
https://www.stratagemmarketinsights.com/report/follicular-lymphoma-therapeutic-market-194670
Follicular Lymphoma Therapeutic Market Insight, Size, Share, Growth, Up-To-Date Key Trends,...
Follicular Lymphoma Therapeutic Market Insight, Size, Share, Growth, Up-To-Date Key Trends, Regional Outlook, and Forecast - 2030
up to datefollicular lymphomamarket insightkey trendstherapeutic
https://news.med.miami.edu/sylvester-study-leads-to-updated-national-guidelines-for-follicular-lymphoma-treatment/
Sylvester Study Leads to Updated National Guidelines for Follicular Lymphoma Treatment - InventUM
May 14, 2025 - Sylvester researchers published positive data on a new treatment regimen for patients with relapsed or refractory follicular lymphoma.
leads tonational guidelinesfollicular lymphomasylvesterstudy
https://powerfulpatients.org/tag/relapsed-follicular-lymphoma-treatment/
relapsed follicular lymphoma treatment Archives - Patient Empowerment Network
follicular lymphomapatient empowermenttreatmentarchivesnetwork
https://iris.uniupo.it/handle/11579/145799
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis,...
clinical practice guidelinesnewly diagnosedfollicular lymphomaesmodiagnosis
https://www.cancernetwork.com/view/routine-use-maintenance-therapy-follicular-lymphoma-examine-rationale-maintenance-use-uniformly
Routine Use of Maintenance Therapy in Follicular Lymphoma: Examine the Rationale for Maintenance...
May 11, 2026 - While definitions of follicular lymphoma maintenance therapy in clinical trials and clinical practice have been somewhat variable, ideally maintenance therapy...
maintenance therapyfollicular lymphomaroutineuseexamine
https://edoc.ub.uni-muenchen.de/22179/
Risk prediction for patients with follicular lymphoma and chronic lymphocytic leukemia
chronic lymphocytic leukemiarisk predictionfor patientsfollicular lymphoma
https://pure.amsterdamumc.nl/en/publications/follicular-lymphoma-international-prognostic-index/
Follicular lymphoma international prognostic index - Amsterdam UMC
follicular lymphomaamsterdam umcinternationalindex
https://oncohemakey.com/follicular-lymphoma-treatment-for-early-stage-grades-1-and-2-and-advanced-stage-disease/
Follicular Lymphoma: Treatment for Early-Stage, Grades 1 and 2, and Advanced-Stage Disease |...
follicular lymphomatreatment forearly stagegradesadvanced
https://medtruth.com/articles/fda-regulation/fda-follicular-lymphoma/
FDA Approves New Drug To Treat Follicular Lymphoma | MedTruth - Prescription Drug & Medical Device...
The FDA has approved a new drug to treat follicular lymphoma, a type of non-Hodgkin's lymphoma that typically affects patients over 60.
follicular lymphomamedical devicefdaapprovesnew
https://www.elsevier.es/en-revista-medicina-clinica-english-edition--462-estadisticas-follicular-lymphoma-as-cause-limbic-S2387020623004539
Follicular lymphoma as a cause of limbic encephalitis associated to anti-Zic4 antibodies | Medicina...
follicular lymphomalimbic encephalitiscauseassociatedanti
https://www.ppf.eu/en/insights/biotech-market/february-2025-biotechnology-review-of-news-from-the-most-innovative-therapeutic-a/odronextamab-bla-accepted-for-fda-review-for-the-treatment-of-follicular-lymphoma
PPF Group | Odronextamab BLA accepted for FDA review for the treatment of follicular lymphoma
Apr 1, 2025 - PPF Group is an international investment group founded in the Czech Republic in 1991. It has grown to manage operations in 25 countries around the world.
the treatmentfollicular lymphomappfgroupbla
https://medispress.com/medical-condition/follicular-lymphoma/
Follicular Lymphoma Overview and Care Resources
Follicular Lymphoma resources for patients and caregivers. Compare staging and grading basics, treatment terms, access notes, and medication information in one...
follicular lymphomacare resourcesoverview
https://www.mskcc.org/clinical-updates/very-low-dose-radiotherapy-effective-grade-3a-follicular-lymphoma
Very Low-Dose Radiotherapy Effective for Grade 3A Follicular Lymphoma | Memorial Sloan Kettering...
Very low-dose radiotherapy (VLDRT) is effective for treating grade 3A follicular lymphoma and provides patients with a shorter treatment course and fewer side...
memorial sloan ketteringvery lowfollicular lymphomadoseradiotherapy
https://www.ispor.org/vih-articles/Volume-10--Issue-6/PCN49-COST-UTILITY-ANALYSIS-OF-MAINTENANCE-THERAPY-WITH-RITUXIMAB-FOR-FOLLICULAR-LYMPHOMA-IN-BRAZIL
PCN49 COST-UTILITY ANALYSIS OF MAINTENANCE THERAPY WITH RITUXIMAB FOR FOLLICULAR LYMPHOMA IN BRAZIL
utility analysismaintenance therapyfollicular lymphomacostbrazil
https://www.mjhid.org/index.php/mjhid/article/view/2016.041/pdf
View of LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
follicular lymphomaradiation therapyviewlimitedstage
https://www.neobiotechnologies.com/product/bcl-2-apoptosis-follicular-lymphoma-marker-16/
Bcl-2 (Apoptosis & Follicular Lymphoma Marker) Antibody - Clone BCL2/6915 - Gene ID 596
follicular lymphomabclapoptosismarkerantibody
https://acervodigital.unesp.br/handle/11449/37733
Acervo Digital: IMMUNOCYTOCHEMICAL DIFFERENTIATION OF REACTIVE HYPERPLASIA FROM FOLLICULAR LYMPHOMA...
acervo digitalfollicular lymphomadifferentiationreactive
https://www.tempus.com/news/tempus-and-ifli-announce-study-to-advance-follicular-lymphoma-research/
Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research - Tempus
Nov 14, 2025 - Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a new research study sponsored by...
follicular lymphomatempusannouncestudyadvance
https://www.centerwatch.com/clinical-trials/listings/condition/783/follicular-lymphoma
Follicular Lymphoma Clinical Research Trials | CenterWatch
Follicular lymphoma is a type of non-Hodgkin lymphoma that originates in the B-cells of the lymphatic system. It is characterized by the formation of abnormal...
clinical research trialsfollicular lymphomacenterwatch
https://www.materresearch.org.au/news-publications/news/2023/may/bostongene-and-mater-research-collaborate-in-new-follicular-lymphoma-study
BostonGene and Mater Research collaborate in new follicular lymphoma study - Mater Research
mater researchfollicular lymphomacollaboratenewstudy
https://amsdottorato.unibo.it/id/eprint/10194/
Evaluation of the pathogenetic role of cellular subsets of the Follicular Lymphoma Microenvironment
follicular lymphomaevaluationrolecellularmicroenvironment
https://researchconnect.stonybrook.edu/en/publications/computerized-microscopic-image-analysis-of-follicular-lymphoma/
Computerized microscopic image analysis of follicular lymphoma - Stony Brook University
stony brook universityimage analysisfollicular lymphomacomputerizedmicroscopic
https://iro.uiowa.edu/esploro/outputs/abstract/Bioflipi-scores-define-distinct-immune-profiles/9985116065502771
Bioflipi scores define distinct immune profiles in follicular lymphoma - University of Iowa
Despite a characteristic indolent course, a substantial subset of follicular lymphoma (FL) patients has an early relapse with a poor outcome. Thus far, efforts...
university of iowafollicular lymphomascoresdefinedistinct
https://consultqd.clevelandclinic.org/bispecific-antibody-shows-deep-remission-and-low-symptom-burden-in-patients-with-relapsedrefractory-follicular-lymphoma
Bispecific Antibody Promising in R/R Follicular Lymphoma
Heavily pretreated patients experience improved progression-free survival and quality of life with CD20xCD3 therapy
bispecific antibodyfollicular lymphomapromising
https://www.hmpgloballearningnetwork.com/site/frmc/news/globin-study-reports-promising-first-line-outcomes-follicular-lymphoma
GLOBIN Study Reports Promising First-Line Outcomes in Follicular Lymphoma
First-line glofitamab plus obinutuzumab (GLOBIN) achieved a 100% response rate with manageable toxicity in patients with high-tumor burden follicular lymphoma,...
study reportsfirst linefollicular lymphomapromisingoutcomes
https://www.2minutemedicine.com/tag/follicular-lymphoma/
follicular lymphoma | 2 Minute Medicine
follicular lymphomaminutemedicine
https://synapse.patsnap.com/disease/cc9b57cf1baf44a1b4fd02ea8efbe5f9
Refractory Follicular Lymphoma - Drugs, Targets, Patents - Synapse
Follicular lymphoma grade I, II, III that is resistant to treatment.
follicular lymphomarefractorydrugstargetspatents
https://pubmed.ncbi.nlm.nih.gov/37683053/
Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated...
The Nordic Lymphoma Study Group has performed two randomized clinical trials with chemotherapy-free first-line treatment (rituximab +/- interferon) in...
gene expressionfollicular lymphomacopynumberprofiling
https://www.ipsen.com/annualreport/clinical_study_indications/relapsed-follicular-lymphoma/
Relapsed Follicular Lymphoma Archives - Annual Report
follicular lymphomaarchives annualreport
https://www.atlantis-press.com/proceedings/orlhn-21/125970626
Follicular Lymphoma Mimicking a Benign Submandibular Gland Tumor | Atlantis Press
Follicular lymphoma of the submandibular gland is exceptionally uncommon. Lymphomas within the head and neck region do not have particular clinical behavior...
follicular lymphomasubmandibular glandatlantis pressbenigntumor
https://www.healthresearchbc.ca/award/high-resolution-analysis-rearrangements-follicular-lymphoma-genomes-using-high-throughput-bac-clone/
High resolution analysis of rearrangements in follicular lymphoma genomes using high-throughput BAC...
Jan 15, 2026 - Follicular lymphoma is a cancer of the lymphocytes (cells of the immune system) and is the most prevalent type of lymphoma in Canada. Most follicular lymphomas...
high resolutionfollicular lymphomaanalysisgenomesusing
https://www.mdanderson.org/newsroom/archived-news/vaccine-increases-disease-free-survival-for-follicular-lymphoma-.h00-158671845.html
ARCHIVED: Vaccine Increases Disease-Free Survival for Follicular Lymphoma Patients | UT MD Anderson
ut md andersonfollicular lymphomaarchivedvaccineincreases
https://pharsight.greyb.com/therapeutics/follicular-lymphoma
Drug Therapeutics of Follicular Lymphoma
A detailed list of the drug therapeutics of Follicular Lymphoma, along with the patent title, drug patent expiry date, ingredients, treatments and dosage...
follicular lymphomadrugtherapeutics
https://pure.jbnu.ac.kr/en/publications/in-situ-follicular-lymphoma-developed-after-hodgkin-lymphoma/
In situ follicular lymphoma developed after Hodgkin lymphoma - JBNU Researchers Portal - Pure
in situfollicular lymphomadevelopedhodgkinresearchers
https://christie.openrepository.com/entities/publication/38deaee7-3895-40b1-bcd7-ab46e307c682
Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter...
New treatments are required for rituximab-refractory follicular lymphoma (FL). In the present study, patients with rituximab-refractory FL received 8 weekly...
follicular lymphomaresults fromofatumumabrefractory
https://open.library.emory.edu/concern/publications/6cfa92db-2f7f-4434-9ad6-699f3c1e19cd
The Use and Effectiveness of Rituximab Maintenance in Patients with Follicular Lymphoma Diagnosed...
The Use and Effectiveness of Rituximab Maintenance in Patients with Follicular Lymphoma Diagnosed Between 2004 and 2007 in the United States
in patientsfollicular lymphomauseeffectivenessmaintenance
https://boris-portal.unibe.ch/entities/publication/993e412f-9f08-4341-8cdc-1c7679c9a223
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma...
BACKGROUND Early treatment failure (ETF) in follicular lymphoma (FL), defined as relapse or progression within 2 years of frontline chemoimmunotherapy, is a...
in patientsfollicular lymphomaautologoustransplantationversus
https://r10.risteys.finngen.fi/endpoints/CD2_FOLLICULAR_LYMPHOMA
Risteys FinnGen R10 - CD2_FOLLICULAR_LYMPHOMA
follicular lymphomaristeys
https://ascopost.com/news/april-2026/bispecific-antibody-shows-deep-remission-in-patients-with-relapsedrefractory-follicular-lymphoma/
Bispecific Antibody Shows Deep Remission in Patients With Relapsed/Refractory Follicular Lymphoma -...
A population of patients with highly refractory follicular lymphoma achieved long-standing responses with few significant adverse events from odronextamab...
bispecific antibodyin patientsfollicular lymphomashowsdeep
https://www.chemdiv.com/company/media/pharma-news/2020/fda-oks-epizymes-tazemetostat-for-treatment-resistant-follicular-lymphoma/
FDA OKs Epizyme's tazemetostat for treatment-resistant follicular lymphoma -...
FDA OKs Epizyme's tazemetostat for treatment-resistant follicular lymphoma
follicular lymphomafdaokstazemetostattreatment
https://ctv.veeva.com/study/phase-ii-cancer-vaccine-trial-for-patients-with-follicular-lymphoma
Phase II Cancer Vaccine Trial for Patients With Follicular Lymphoma
Patients with non-curable disseminated follicular lymphoma receive local radiotherapy targeting single lymph nodes and injection of low-dose rituximab...
phase iicancer vaccinefor patientsfollicular lymphomatrial
https://www.e-roj.org/journal/view.php?number=154&viewtype=pubreader
Radiotherapy as an effective treatment modality for follicular lymphoma: a single institution...
effective treatmentfollicular lymphomaradiotherapymodalitysingle
https://moneycompass.com.my/pepromene-bio-inc-and-the-institute-for-follicular-lymphoma-innovation-announce-11m-investment-to-advance-pmb-ct01-baff-r-car-t-cell-therapy-for-relapsed-refractory-follicular-lymphoma/
PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment...
Dec 19, 2024 - Based on promising early clinical results from PeproMene Bio's PMB-102 Phase 1 study, they will receive $6M USD upfront plus an
the institutefollicular lymphomabioincinnovation
https://s10.ai/blog/c83-icd10-code-for-non-follicular-lymphoma
C83: ICD10 Code for Non-follicular lymphoma
follicular lymphomacodenon
https://statsnexmarketinsights.com/reports/follicular-lymphoma-treatment-market
Follicular Lymphoma Treatment Market Size ($11.2 Billion) by 2032
Follicular Lymphoma Treatment Market valued at $7.5 Billion in 2026, projected to reach $11.2 Billion by 2032 at a 7.0% CAGR. Statsnex analysis covering...
follicular lymphomamarket sizetreatmentbillion
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-epcoritamab-bysp-relapsed-or-refractory-follicular-lymphoma
FDA grants accelerated approval to epcoritamab-bysp for relapsed or refractory follicular lymphoma...
On June 26, 2024, the Food and Drug Administration granted accelerated approval to epcoritamab-bysp (Epkinly, Genmab US, Inc.), a bispecific CD20-directed CD3...
follicular lymphomafdagrantsacceleratedapproval
https://theafricalogistics.com/tempus-and-ifli-partner-to-advance-targeted-therapies/
Tempus and IFLI Partner to Advance Targeted Therapies for Follicular Lymphoma -...
Feb 13, 2025 - empus AI, Inc., a leading technology company specializing in precision medicine, has announced a strategic collaboration with the Institute for Follicular...
targeted therapiesfollicular lymphomatempuspartneradvance
https://ecancer.org/en/news/27860-fifteen-year-results-from-swog-s0016-trial-suggest-follicular-lymphoma-is-curable
Fifteen-year results from SWOG S0016 trial suggest follicular lymphoma is curable - ecancer
Unlike some other forms of lymphoma, advanced stage follicular lymphoma is considered incurable. But a new analysis of long-term data on patients treated for
year resultsfollicular lymphomafifteentrialsuggest
https://cris.bgu.ac.il/en/publications/rituximab-maintenance-for-the-treatment-of-patients-with-follicul-3/
Rituximab maintenance for the treatment of patients with follicular lymphoma: An updated systematic...
for thefollicular lymphomamaintenancetreatmentpatients
https://e-crt.org/journal/view.php?viewtype=pubreader&number=30
A Rare Presentation of Follicular Lymphoma: Cerebellar Involvement, Successfully Treated with a...
follicular lymphomararepresentationinvolvementsuccessfully
https://exactitudeconsultancy.com/reports/70852/follicular-lymphoma-market
Follicular Lymphoma Market Analysis and Trends 2023
The Follicular Lymphoma Market Is Set To Grow At An Estimated CAGR Of 5.5% From 2025 To 2034, Rising From $12 Billion In 2024 To $18 Billion By 2034.
follicular lymphomamarket analysistrends
https://zenonco.io/cancer/follicular-lymphoma/
Follicular Lymphoma
Discover insights into Follicular Lymphoma, including innovative treatment strategies, research findings, and resources for patients and caregivers.
follicular lymphoma
https://www.aapc.com/codes/icd-10-codes/C82.09
ICD-10 Code for Follicular lymphoma grade I, extranodal and solid organ sites- C82.09- Codify by...
ICD-10 code C82.09 for Follicular lymphoma grade I, extranodal and solid organ sites is a medical classification as listed by WHO under the range -Mal
follicular lymphomaicdcodegradesolid
https://reachmd.com/programs/project-oncology/beyond-disease-control-pros-with-odronextamab-in-rr-follicular-lymphoma/37208/
PROs With Odronextamab in R/R Follicular Lymphoma
In relapsed or refractory follicular lymphoma, disease control is only part of the equation.
follicular lymphomapros